Evidence map›Paper›PMID 33640513›Full record

ReviewJournal of the American Academy of Dermatology2021

Visible light. Part II: Photoprotection against visible and ultraviolet light.

Amaris N Geisler, Evan Austin, Julie Nguyen, Iltefat Hamzavi, Jared Jagdeo, Henry W Lim

Open access · greenAbstract readReview
In one paragraph

Review in Journal of the American Academy of Dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 108 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Global consensus on the management of melanin hyperpigmentation disorders.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Sunscreens in pigmentary disorders: time to revise the message.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Amaris N GeislerCUNY School of Medicine, New York, New York.
Evan AustinDepartment of Dermatology, Center for Photomedicine, SUNY Downstate Medical Center, Brooklyn, New York; Dermatology Service, VA New York Harbor Healthcare System, Brooklyn, New York.
Julie NguyenDepartment of Dermatology, Center for Photomedicine, SUNY Downstate Medical Center, Brooklyn, New York; Dermatology Service, VA New York Harbor Healthcare System, Brooklyn, New York.
Iltefat HamzaviDepartment of Dermatology, Photomedicine and Photobiology Unit, Henry Ford Health System, Detroit, Michigan.
Jared JagdeoDepartment of Dermatology, Center for Photomedicine, SUNY Downstate Medical Center, Brooklyn, New York; Dermatology Service, VA New York Harbor Healthcare System, Brooklyn, New York. Electronic address: jrjagdeo@gmail.com.
Henry W LimDepartment of Dermatology, Photomedicine and Photobiology Unit, Henry Ford Health System, Detroit, Michigan.
Henry Ford Health System · USSUNY Downstate Health Sciences University · USCUNY School of Law · USVA NY Harbor Healthcare System · US

Funding

Light Emitting Diod-Red Light Phototherapy for Skin FibrosisK23GM117309 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JAGDEO, JARED R · 2016 to 2019
$777k
NIGMS NIH HHS K23 GM117309
6 · The paper itself

Abstract

Cutaneous photobiology studies have focused primarily on the ultraviolet portion of the solar spectrum. Visible light (VL), which comprises 50% of the electromagnetic radiation that reaches the Earth's surface and, as discussed in Part I of this CME, has cutaneous biologic effects, such as pigment darkening and erythema. Photoprotection against VL includes avoiding the sun, seeking shade, and using photoprotective clothing. The organic and inorganic ultraviolet filters used in sunscreens do not protect against VL, only tinted sunscreens do. In the United States, these filters are regulated by the Food and Drug Administration as an over-the-counter drug and are subject to more stringent regulations than in Europe, Asia, and Australia. There are no established guidelines regarding VL photoprotection. Alternative measures to confer VL photoprotection are being explored. These novel methods include topical, oral, and subcutaneous agents. Further development should focus on better protection in the ultraviolet A1 (340-400 nm) and VL ranges while enhancing the cosmesis of the final products.

Indexed as

Administration, CutaneousAdministration, OralErythemaHumansInjections, SubcutaneousRadiation-Protective AgentsSkinSkin PigmentationSunlightTreatment OutcomeUltraviolet RaysRadiation-Protective Agentsinorganic filterlight filterorganic filterphotolyasephotoprotectionsunblocksunscreenultraviolet lightvisible lightvisible light photoprotection

Identifiers

PMID33640513
PMCPMC8887048
OpenAlexW3132382331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.